About Teradyne
Teradyne
(NYSE:
TER) is a leading supplier of automation equipment for test and
industrial applications. Teradyne Automatic Test Equipment (ATE) is used
to test semiconductors, wireless products, data storage and complex
electronic systems, which serve consumer, communications, industrial and
government customers. Our Industrial Automation products include
Collaborative Robots used by global manufacturing and light industrial
customers to improve quality and increase manufacturing efficiency. In
2015, Teradyne had revenue of $1.64 billion and currently employs
approximately 4,100 people worldwide. For more information, visit
www.teradyne.com.
Teradyne (R) is a registered trademark of Teradyne, Inc. in the U.S. and
other countries.
Safe Harbor Statement
This release contains forward-looking
statements regarding future business prospects, Teradyne’s results of
operations, market conditions, the payment of a quarterly dividend, the
repurchase of Teradyne common stock pursuant to a share repurchase
program and a senior secured credit facility. Such statements are based
on the current assumptions and expectations of Teradyne’s management and
are neither promises nor guarantees of future performance, future
events, future payment of dividends, future repurchases of common stock
or future availability of, or borrowing under, a credit facility. There
can be no assurance that management’s estimates of Teradyne’s future
results or other forward-looking statements will be achieved.
Additionally, the current dividend and share repurchase programs may be
modified, suspended or discontinued at any time. Important factors that
could cause actual results, dividend payments, repurchases of common
stock or borrowings under the credit facility to differ materially from
those presently expected include: conditions affecting the markets in
which Teradyne operates; decreased or delayed product demand; market
acceptance of new products; the ability to grow Universal Robots’
business; increased research and development spending; deterioration of
Teradyne’s financial condition; the business judgment of the board of
directors that a declaration of a dividend, the repurchase of common
stock or debt under the credit facility is not in the company’s best
interests; and other events, factors and risks disclosed in filings with
the SEC, including, but not limited to, the “Risk Factors” section of
Teradyne’s Annual Report on Form 10-K for the fiscal year ended December
31, 2014 and the Quarterly Report on Form 10-Q for the period ended
October 4, 2015. The forward-looking statements provided by Teradyne in
this press release represent management’s views as of the date of this
release. Teradyne anticipates that subsequent events and developments
may cause management's views to change. However, while Teradyne may
elect to update these forward-looking statements at some point in the
future, Teradyne specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as representing
Teradyne's views as of any date subsequent to the date of this release.
CONDENSED CONSOLIDATED OPERATING STATEMENTS | ||||||||||||||||||||
(In thousands, except per share amounts) | ||||||||||||||||||||
Quarter Ended | Twelve Months Ended | |||||||||||||||||||
December 31,
|
October 4,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
Net revenues | $ | 318,444 | $ | 465,994 | $ | 323,236 | $ | 1,639,578 | $ | 1,647,824 | ||||||||||
Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1) (2) | 152,418 | 207,368 | 163,010 | 723,935 | 769,016 | |||||||||||||||
Gross profit | 166,026 | 258,626 | 160,226 | 915,643 | 878,808 | |||||||||||||||
Operating expenses: | ||||||||||||||||||||
Engineering and development (1) | 70,941 | 74,027 | 79,188 | 292,250 | 291,639 | |||||||||||||||
Selling and administrative (1) (3) | 79,718 | 77,481 | 91,157 | 306,313 | 319,713 | |||||||||||||||
Acquired intangible assets amortization | 19,911 | 20,053 | 15,957 | 69,031 | 70,771 | |||||||||||||||
Goodwill impairment |
- | - | 98,897 | - | 98,897 | |||||||||||||||
Restructuring and other (4) | 5,204 | 261 | 1,198 | 5,080 | 1,365 | |||||||||||||||
Operating expenses | 175,774 | 171,822 | 286,397 | 672,674 | 782,385 | |||||||||||||||
(Loss) income from operations | (9,748 | ) | 86,804 | (126,171 | ) | 242,969 | 96,423 | |||||||||||||
Interest and other (5) | 891 | 604 | 1,358 | 10,155 | (1,047 | ) | ||||||||||||||
(Loss) income before income taxes | (8,857 | ) | 87,408 | (124,813 | ) | 253,124 | 95,376 | |||||||||||||
Income tax (benefit) provision | (8,216 | ) | 15,955 | (21,002 | ) | 46,647 | 14,104 | |||||||||||||
Net (loss) income | $ | (641 | ) | $ | 71,453 | $ | (103,811 | ) | $ | 206,477 | $ | 81,272 | ||||||||
Net (loss) income per common share: | ||||||||||||||||||||
Basic | $ | (0.00 | ) | $ | 0.34 | $ | (0.48 | ) | $ | 0.98 | $ | 0.40 | ||||||||
Diluted | $ | (0.00 | ) | $ | 0.34 | $ | (0.48 | ) | $ | 0.97 | $ | 0.37 | ||||||||
Weighted average common shares - basic | 205,113 | 210,032 | 216,532 | 211,544 | 202,908 | |||||||||||||||
Weighted average common shares - diluted (6) | 205,113 | 211,736 | 216,532 | 213,321 | 222,550 | |||||||||||||||
Cash dividend declared per common share | $ | 0.06 | $ | 0.06 | $ | 0.06 | $ | 0.24 | $ | 0.18 | ||||||||||
Net orders | $ | 522,240 | $ | 314,222 | $ | 331,993 | $ | 1,855,515 | $ | 1,681,950 | ||||||||||
(1)Pension actuarial losses included in our operating results were as follows: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31,
|
October 4,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
Cost of revenues | $ | 8,271 | $ | - | $ | 12,713 | $ | 8,271 | $ | 12,713 | ||||||||||
Engineering and development | 4,658 | - | 12,223 | $ | 4,658 | 12,223 | ||||||||||||||
Selling and administrative | 4,826 | - | 21,628 | $ | 4,826 | 21,628 | ||||||||||||||
$ | 17,755 | $ | - | $ | 46,564 | $ | 17,755 | $ | 46,564 | |||||||||||
(2)Cost of revenues includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31,
|
October 4,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
Provision for excess and obsolete inventory | $ | 2,393 | $ | 3,058 | $ | 688 | $ | 21,332 | $ | 22,193 | ||||||||||
Sale of previously written down inventory | (1,196 | ) | (1,983 | ) | (3,332 | ) | (7,855 | ) | (13,058 | ) | ||||||||||
Inventory step-up | - | 972 | - | 1,567 | - | |||||||||||||||
$ | 1,197 | $ | 2,047 | $ | (2,644 | ) | $ | 15,044 | $ | 9,135 | ||||||||||
(3)For the twelve months ended December 31, 2014, selling and administrative expenses include an equity charge of $6,598 for the modification of Teradyne's retired CEO's outstanding equity awards to allow continued vesting and maintain the original term in connection with his January 31, 2014 retirement. | ||||||||||||||||||||
(4)Restructuring and other consists of: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31,
|
October 4,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
Employee severance | $ | 115 | $ | 1,117 | $ | 826 | $ | 1,487 | $ | 1,623 | ||||||||||
Acquisition costs (a) | - | 144 | 372 | 1,104 | 372 | |||||||||||||||
Contingent consideration fair value adjustment | 5,089 | (1,000 | ) | - | 2,489 | (630 | ) | |||||||||||||
$ | 5,204 | $ | 261 | $ | 1,198 | 5,080 | $ | 1,365 | ||||||||||||
(a)Costs related to Universal Robots acquisition. The results of Universal Robots are included in Teradyne’s results starting June 12, 2015. | ||||||||||||||||||||
(5)Interest and other includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||
December 31,
|
October 4,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
Gain from the sale of an equity investment | $ | - | $ | - | $ | - | $ | (5,406 | ) | $ | - | |||||||||
Non-cash convertible debt interest expense | - | - | - | - | 4,290 | |||||||||||||||
$ | - | $ | - | $ | - | $ | (5,406 | ) | $ | 4,290 | ||||||||||